ArticleResearch square2026
Experiences of Full Body Skin Examinations among Sexual and Gender Minority Patients in Dermatology: A Qualitative Study.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sexual and gender minority (SGM) patients experience disproportionate skin cancer risk and barriers to preventive dermatologic care access relative to non-SGM counterparts. Yet SGM may be deterred from the full body skin exam (FBSE) for screening due to fear of stigma surrounding their bodies. There is a dearth of qualitative research about SGM patients' perceptions of the FBSE. To address this gap, we surveyed 175 SGM-identifying patients; 161 provided qualitative responses describing whether their sexual or gender identity (SOGI) influences their decision to undergo a FBSE and why. We identified pervasive themes of discomfort, fear of clinician discrimination (anticipatory stigma), and prior discriminatory experiences. The 69.6% of participants who reported their SOGI did not influence their decision to undergo a FBSE most commonly described enduring the FBSE for health benefits despite significant discomfort. Among the remaining 30.4% of participants, discomfort was substantial enough to influence their decision to undergo a FBSE, with 75.5% citing fear of clinician discrimination as a cause for hesitation. Forty-six participants provided specific recommendations to improve the FBSE experience for SGM, including: providing gowns and chaperones, visible displays of allyship (e.g. flags), offering SGM-specific care (e.g. for top surgery scars), affirming communication (correct pronoun use and avoiding anatomy assumptions), eliciting trauma history, and continuous consent throughout the exam. Across responses, a unifying theme was that clinicians' lack of understanding about SGM experiences contributed substantially to patient discomfort. Our findings suggest that fear of clinician discrimination and past discriminatory experiences may discourage some SGM patients from undergoing FBSEs, which may exacerbate existing health disparities burdening this population. These findings underscore the need for SGM-specific education and bias reduction in dermatologic training.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.